European Genomic Data Infrastructure [1]
In short
[2]The Genomics Data Infrastructure (GDI) project enables access to genomic and related phenotypic and clinical data across Europe. We do this by establishing a federated, sustainable and secure infrastructure to access the data. It builds on the outputs of the Beyond 1 Million Genomes (B1MG) [3] project and realises the ambition of the 1+Million Genomes (1+MG) [4] initiative, which has a Belgian Mirror Group, coördinated by Sciesano.
Project description
This project accomplishes the 1+MG initiative [6]’s ambition to enable secure access to genomics and corresponding clinical data across Europe by creating data infrastructure. The project involves a consortium of partners from 20 European countries and facilitates a cross-border federated network of national genome collections for biomedical research and personalised medicine solutions. The GDI project aims to unlock a data network of over one million genome sequences for research and clinical reference. This creates unprecedented opportunities for transnational and multi-stakeholder actions in personalised medicine for common, rare and infectious diseases.
Authorised data users, such as clinicians, researchers and innovators, will be able to advance understanding of genomics for more precise and faster clinical decision-making, diagnostics, treatments and predictive medicine, and for improved public health measures to benefit European citizens, healthcare systems and the overall economy.
As a critical component of Europe’s ambition to lead the integration of genomics into healthcare, the GDI project makes data accessible for research, clinical reference and policy development uses through three key ‘pillars’:
- Long term sustainability (governance model, legal framework, financial plan for the infrastructure)
- Infrastructure deployment (Interoperability of European data resources)
- Use cases (e.g. cancer and infectious disease data)
Sciensano, through the Belgian Cancer Centre, co-leads pillar 3 (use case on cancer) and contributes to the development of data-driven models for cancer research.
Consortium
Partners
- 44 partners
- 20 countries
Belgian Partners
- Sciensano
- VIB
- Interuniversity Microelectronics Centre (IMEC)
Structure
| Work Package (WP) | Leading Institute, Country |
| WP1 Coordination and support | EMBL, Germany |
| WP2 Long-term sustainability | UNILU, Luxemburg |
| WP3 Deployment of 1+MG national nodes | UU, Sweden |
| WP4 European level operations | UNILU, Luxemburg |
| WP5 Technical coordination and outread | CSC, Finland |
| WP6 Data Management | HRI, The Netherlands |
| WP7 GDI use cases | BSC, Spain |
| WP8 Application and innovation solution | BSC; Spain |
Related projects
- Belgian ‘Europe’s Beating Cancer Plan’ Mirror Group [7] (BE EBCP)
Technical information
| Work Program | DIGITAL-2021-CLOUD-A1-01 / Project: 101081813 |
| Budget | €40M |
| Lead Coordinator | European Molecular Biology Labratory (EMBL), Germany |
| Domain / Area | European Health Data Space |
Contact us [8]
Results
As a result of the project, GDI has produced three videos that explain the 1+MG initiative [6] and their ambitions in a clear and concice way;
- What is the 1+Million Genomes Initiative? [9]
- 1+Million Genomes Shaping the Future of Patient Care [10]
- 1+Million Genomes Transforming Health Together [11]
[12]
Visit the youtube channel [13]
Sciensano's project investigator(s):
Service(s) working on this project
Partners
Financial Source
